Corcept Therapeutics Aktie
60,68
EUR
-0,10
EUR
-0,16
%
70,08
USD
+0,25
USD
+0,36
%
Werbung
Corcept Therapeutics Aktie Analyse
04.02.19 | Corcept Therapeutics Neutral | B. Riley FBR | |
10.08.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
31.05.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
09.03.18 | Corcept Therapeutics Buy | B. Riley FBR, Inc. | |
31.08.17 | Corcept Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
21.04.15 | Corcept Therapeutics Outperform | FBR Capital | |
02.11.09 | Corcept Therapeutics kaufen | Global Biotech Investing | |
28.08.06 | Corcept Therapeutics Market Perform | Punk, Ziegel & Co | |
Werbung
|
|||
15.08.05 | Corcept Therapeutics Buy | Punk, Ziegel & Co | |
25.04.05 | Corcept Therapeutics Outperform | Harris Nesbitt |
Werbung
Werbung